Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Greater Pacific Capital is a private equity and impact investment firm founded in 2005 that focuses on building market-leading businesses across Asia, with a particular emphasis on India and its links to global markets. The firm describes its strategy as combining investing, impact, and in-house macro and strategic research, with investment themes including financial inclusion, energy transition, digital inclusion, and gender equality. It is not an operating biotech, pharma, or healthcare company, though healthcare is one of the sectors represented in its investment portfolio. Greater Pacific Capital appears to operate through entities including Greater Pacific Capital LLP in London and Greater Pacific Capital India Private Limited in Mumbai. Its business is investment management and portfolio development rather than drug discovery, clinical development, or healthcare service delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Greater Pacific Capital.